Causal attributions for raised cholesterol and perceptions of effective risk-reduction: Self-regulation strategies for an increased risk of coronary heart disease

Psychology and Health

Volumn 22, Issue 6, 2007, Pages 699-717

  Senior, Victoria ^a,b   Marteau, Theresa M ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Causal attribution; Cholesterol; Coronary heart disease; Genetic testing; Perceived control; Self regulation

Indexed keywords

EID: 34547372351     PISSN: 08870446     EISSN: 14768321     Source Type: Journal    
DOI: 10.1080/14768320601020253     Document Type: Article

References (24)

1. Audrain, J., Boyd, N. R., Roth, J., Main, D., Caporaso, N. E., & Lerman, C. (1997). Genetic susceptibility testing in smoking-cessation treatment: One-year outcomes of a randomised trial. Addictive Behaviors, 22, 741-751.
2. Bandura, A. (1977). Self-efficacy: Toward a unifying theory of behavioral change. Psychological Review, 84, 191-215.
3. Field, A. (2005). Discovering statistics using SPSS. London: Sage Publications.
4. French, D. P., Marteau, T. M., Senior, V., & Weinman, J. (2005). How valid are measures of beliefs about the causes of illness? The example of myocardial infarction. Psychology and Health, 20, 615-635.
5. Heath, K. E., Humphries, S. E., Middleton-Price, H., & Boxer, M. (2001). A molecular genetic service for diagnosing individuals with familial hypercholesterolaemia (FH). European Journal of Human Genetics, 9, 244-252.
6. Home, R., & Weinman, J. (1999). Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. Journal of Psychosomatic Research, 47, 555-567.
7. Lerman, C., Gold, K., Boyd, N. R., Orleans, G. T., Wilfond, B., Louben, G., et al. (1997). Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: Effects of smoking-related cognitions, emotions, and behavior. Health Psychology, 16, 87-99.
8. Leventhal, H., Benyamini, Y., Brownlee, S., Diefenbach, M., Leventhal, E. A., Patrick-Miller, L., et al. (1997). Illness representations: Theoretical foundations. In K. J. Petrie & J. A. Weinman (Eds), Perceptions of health and Illness: Current research and applications (pp. 19-45). Amsterdam: Harwood Academic Publishers.
9. Marteau, T. M., & Lerman, C. (2001). Genetic risk and behavioural change. British Medical Journal, 322, 1056-1059.
10. Marteau, T. M., Senior, V., Humphries, S. E., Bobrow, M., Cranston, T., Crook, M.A., et al. (2004). Psychological impact of genetic testing for Familial Hypercholesterolaemia (FH) within an aware population: A randomised controlled trial. American Journal of Medical Genetics, 128, 285-293.
11. McClure, J. B. (2002). Are biomarkers useful treatment aids for promoting health behavior change? An empirical review. American Journal of Preventive Medicine, 22, 200-207.
12. McBride, C. M., Halabi, S., Bepler, G., Lyna, P., McIntyre, L., Lipkus, I., et al. (2000). Maximizing the motivational impact of feedback of lung cancer susceptibility on smokers' desire to quit. Journal of Health Communication, 5, 229-241.
13. Marais, A. C., & Firth, J. C. (2005). The diagnosis and management of familial hypercholesterolaemia. European Review for Medical and Pharmacological Sciences, 9, 141-149.
14. Moss-Morris, R., Weinman, J., Petrie, K. J., Home, R., Cameron, L. D., & Buick, D. (2002). The Revised Illness Perception Questionnaire (IPQ-R). Psychology and Health, 17, 1-16.
15. Poustie, V. J., & Rutherford, P. (2001). Dietary treatment for familial hypercholesterolaemia. The Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD001918. DOI: 10.1002/14651858.CD001918.
16. Roe, L., Strong, C., Whiteside, C., Neil, A., & Mant, D. (1994). Dietary intervention in primary care: Validity of the DINE method for dietary assessment. Family Practice, 11, 375-381.
17. Senior, V., Marteau, T. M., & Peters, T. J. (1999). Will genetic testing for predisposition for disease result in fatalism? A qualitative study of parents responses to neonatal screening for familial hypercholesterolaemia. Social Science and Medicine, 48, 1857-1860.
18. Senior, V., Marteau, T. M., & Weinman, J. (2000). Impact of genetic testing on causal models of heart disease and arthritis: An analogue study. Psychology and Health, 14, 1077-1088.
19. Senior, V., Marteau, T. M., & Weinman, J. On behalf of the Genetic Risk Assessment for FH Trial (GRAFT) Study Group (2004). Self-reported adherence to cholesterol-lowering medication in patients with Familial Hypercholesterolaemia: The role of illness perceptions. Cardiovascular Drugs and Therapy, 18, 475-481.
20. Senior, V., Marteau, T. M., & Weinman, J. On behalf of the Genetic Risk Assessment for FH Trial (GRAFT) Study Group (2005). Perceptions of control over heart disease in people with an inherited predisposition to raised cholesterol. Psychology, Health and Medicine, 10, 16-30.
21. Senior, V., Smith, J. A., Michie, S., & Marteau, T. M. (2002). Making sense of risk: An interpretative phenomenological analysis of vulnerability to heart disease. Journal of Health Psychology, 7, 157-168.
22. Simon Broome Steering Committee (1991). Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group. British Medical Journal, 303, 893-896.
23. Simon Broome Steering Committee (1999). Steering committee on behalf of the Simon Broome Register Group. Mortality in treated heterozygous familial hypercholesterolaemia: Implications for clinical management. Atherosclerosis, 142, 105-112.
24. Wright, A. J., Weinman, J., & Marteau, T. M. (2003). The impact of learning of a genetic vulnerability to nicotine addiction: An analogue study. Tobacco Control, 12, 227-230.